Teladoc Health, Inc. (TDOC)

Teladoc Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	679.62	1,298	1,124	918.18	893.48	733.32
Short-Term Investments	-	-	-	-	2.54	53.25
Cash & Short-Term Investments	679.62	1,298	1,124	918.18	896.02	786.57
Cash Growth	-41.53%	15.54%	22.38%	2.47%	13.91%	52.12%
Accounts Receivable	225.43	214.15	217.42	210.55	168.96	169.28
Other Receivables	8.57	9.81	12.64	25.09	21.17	-
Receivables	234.01	223.96	230.06	235.65	190.12	169.28
Inventory	38.16	38.14	29.51	56.34	73.08	56.5
Prepaid Expenses	85.59	67.47	65.65	63.16	38.26	47.26
Other Current Assets	35.9	36.02	40.15	42.06	27.96	-
Total Current Assets	1,073	1,664	1,489	1,315	1,225	1,060
Property, Plant & Equipment	53.17	56.58	72.09	71.47	74.01	75.2
Goodwill	283.19	283.19	1,073	1,073	14,504	14,581
Other Intangible Assets	1,383	1,431	1,678	1,837	1,910	2,021
Long-Term Deferred Charges	60.49	61.86	58.67	33.8	8.85	-
Other Long-Term Assets	40.58	19.63	21.59	14.74	11.85	18.36
Total Assets	2,894	3,517	4,392	4,345	17,735	17,755
Accounts Payable	54.43	33.13	43.64	47.69	47.26	46.03
Accrued Expenses	196.21	198.72	195.52	169.29	142.84	132.58
Current Portion of Long-Term Debt	-	550.72	-	-	13.31	56.01
Current Portion of Leases	9.88	10.34	10.75	13.59	12.69	11.44
Current Income Taxes Payable	-	-	-	3.82	3.1	1.63
Current Unearned Revenue	74.7	79.3	95.66	101.83	75.57	52.36
Other Current Liabilities	66.55	69.33	75.05	63.55	36.25	32.61
Total Current Liabilities	401.77	941.54	420.62	399.77	331.01	332.65
Long-Term Debt	993.17	991.42	1,539	1,535	1,235	1,390
Long-Term Leases	32.05	32.14	42.84	38.04	41.77	43.14
Long-Term Unearned Revenue	10.69	9.79	13.62	11.95	3.83	2.45
Long-Term Deferred Tax Liabilities	29.95	49.85	49.45	50.94	75.78	102.1
Other Long-Term Liabilities	4.25	0.72	1.08	1.62	1.49	1.62
Total Liabilities	1,472	2,025	2,066	2,038	1,689	1,871
Common Stock	0.18	0.17	0.17	0.16	0.16	0.15
Additional Paid-In Capital	17,813	17,759	17,592	17,359	17,473	16,858
Retained Earnings	-16,356	-16,230	-15,229	-15,008	-1,421	-992.66
Comprehensive Income & Other	-35.4	-38.39	-36.99	-42.78	-6.29	18.52
Total Common Equity	1,422	1,491	2,326	2,308	16,046	15,884
Shareholders' Equity	1,422	1,491	2,326	2,308	16,046	15,884
Total Liabilities & Equity	2,894	3,517	4,392	4,345	17,735	17,755
Total Debt	1,035	1,585	1,592	1,587	1,303	1,500
Net Cash (Debt)	-355.47	-286.29	-468.6	-668.74	-406.72	-713.54
Net Cash Per Share	-2.05	-1.68	-2.85	-4.14	-2.59	-7.88
Filing Date Shares Outstanding	176.69	173.67	167.04	162.62	160.33	152.7
Total Common Shares Outstanding	176.61	173.41	166.66	162.84	160.47	150.28
Working Capital	671.5	722.37	1,068	915.62	894.43	726.96
Book Value Per Share	8.05	8.60	13.96	14.17	99.99	105.69
Tangible Book Value	-244.36	-223.47	-424.9	-602.21	-368.7	-718.32
Tangible Book Value Per Share	-1.38	-1.29	-2.55	-3.70	-2.30	-4.78
Machinery	-	74.91	65.76	56.86	46.45	37.03
Construction In Progress	-	0.6	1.72	7.19	1.93	0.66
Leasehold Improvements	-	25.33	24.29	13.3	12.98	12.83

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q